Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111342 Target Snapshot

Dopamine receptor D2 and D3 · SELECTIVITY GROUP · Rattus norvegicus

190Compounds
20Assays
11Approved Drugs
57.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P19020. Use UniProt P19020 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P19020 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dopamine receptor D2 and D3 as ChEMBL target CHEMBL2111342, mapped to UniProt P19020. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dopamine receptor D2 and D3
SELECTIVITY GROUP · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2111342
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P19020
D(3) dopamine receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dopamine receptor D2 and D3 is the right protein anchor across sources, using UniProt P19020 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelD(3) dopamine receptor
UniProt AccessionP19020
Component TypeProtein
Sequence Length446 aa

D(3) dopamine receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dopamine receptor D2 and D3, mapped to UniProt P19020. ChEMBL maps the protein component as D(3) dopamine receptor. Sequence length is 446 aa.

Mapped IDP19020
Review nameDopamine receptor D2 and D3
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

11
Approved
1
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC5018.0
KI32.0
EC505.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL20734 11.0 Kd 0.01 Clinical
CHEMBL285755 10.19 EC50 0.064 Preclinical
CHEMBL219916 8.99 Ki 1.02 Clinical
CHEMBL540612 8.99 IC50 1.02 Preclinical
CHEMBL484599 8.82 EC50 1.5 Preclinical
CHEMBL301265 8.7 EC50 1.98 Approved
CHEMBL54 8.62 Ki 2.39 Approved
CHEMBL589 8.41 EC50 3.89 Approved
CHEMBL531 8.37 EC50 4.31 Approved
CHEMBL715 8.32 Ki 4.8 Approved
Distribution

pChEMBL Value Distribution

3
5.0
4
5.5
4
6.0
2
6.5
6
7.0
8
7.5
7
8.0
7
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

APOMORPHINE
CHEMBL53
Approved 2001
PRAMIPEXOLE
CHEMBL301265
Approved 1997
ROPINIROLE
CHEMBL589
Approved 1997
OLANZAPINE
CHEMBL715
Approved 1996
CLOZAPINE
CHEMBL42
Approved 1989
PERGOLIDE
CHEMBL531
Approved 1988
DOPAMINE
CHEMBL59
Approved 1974
HALOPERIDOL
CHEMBL54
Approved 1967
Assay Landscape

Assay Landscape

20
Total Assays
24
Tested Compounds
2
Assay Types
Binding — 14 assays, 24 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 9 6.2
cell-based format 4 15 7.8
protein format 4 0
cell membrane format 1 0
tissue-based format 1 0
Functional — 6 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 4 0
cell-based format 2 5 8.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine